Summary: The type III secretion apparatus (T3SA) is a multi‐protein complex central to the virulence of many Gram‐negative pathogens. Currently, the mechanisms controlling the hierarchical addressing of needle subunits, translocators and effectors to the T3SA are still poorly understood. In Shigella, MxiC is known to sequester effectors within the cytoplasm prior to receiving the activation signal from the needle. However, molecules involved in linking the needle and MxiC are unknown. Here, we demonstrate a molecular interaction between MxiC and the predicted inner‐rod component MxiI suggesting that this complex plugs the T3SA entry gate. Our results suggest that MxiI–MxiC complex dissociation facilitates the switch in secretion from translocators to effectors. We identified MxiCF206S variant, unable to interact with MxiI, which exhibits a constitutive secretion phenotype although it remains responsive to induction. Moreover, we identified the mxiIQ67A mutant that only secretes translocators, a phenotype that was suppressed by coexpression of the MxiCF206S variant. We demonstrated the interaction between MxiI and MxiC homologues in Yersinia and Salmonella. Lastly, we identified an interaction between MxiC and chaperone IpgC which contributes to understanding how translocators secretion is regulated. In summary, this study suggests the existence of a widely conserved T3S mechanism that regulates effectors secretion.
Type III secretion apparatus (T3SA) are complex nanomachines that insert a translocation pore into the host cell membrane through which effector proteins are injected into the cytosol. In Shigella, the pore is inserted by a needle tip complex that also controls secretion. IpaD is the key protein that rules the composition of the tip complex before and upon cell contact or Congo red (CR) induction. However, how IpaD is involved in secretion control and translocon insertion remains not fully understood. Here, we report the phenotypic analysis of 20 10-amino acids deletion variants all along the coiled-coil and the central domains of IpaD (residues 131–332). Our results highlight three classes of T3S phenotype; (i) wild-type secretion, (ii) constitutive secretion of all classes of effectors, and (iii) constitutive secretion of translocators and early effectors, but not of late effectors. Our data also suggest that the composition of the tip complex defines both the T3SA inducibility state and late effectors secretion. Finally, we shed light on a new aspect regarding the contact of the needle tip with cell membrane by uncoupling the Shigella abilities to escape macrophage vacuole, and to insert the translocation pore or to invade non-phagocytic cells.
Background: Africa experiences a high burden of Streptococcus pyogenes disease but has limited epidemiological data. We characterized emm types and emm clusters associated with carriage and disease in The Gambia, a setting with a high rheumatic heart disease burden. Methods: A 1-year household cohort study (2021–2022) recruited 442 participants from 44 households to assess S. pyogenes carriage and noninvasive infection. Pharyngeal and skin swab samples were collected to detect carriage, and pharyngitis and pyoderma swab samples were taken to assess infection. Cultured isolates underwent emm typing and were compared with previous collection from the same region. Results: A total of 221 cultured isolates showed 52 different emm types and 16 emm clusters. Strain diversity was high (Simpson reciprocal index, 29.3 [95% confidence interval, 24.8–36.0]), with the highest diversity seen in pyoderma and the lowest in pharyngitis. Based on available cross-opsonization data, the 30-valent M-protein vaccine candidate would cover 50.8% of the isolates, but cross-opsonization data are unknown for 38.5% of them. The emm clusters showed lower diversity and were stable over time, with 4 clusters defining 65.2% of the isolates; 68% of isolates were collected from skin sites (carriage and pyoderma), with evidence of skin-to-throat transmission in the same host. Conclusions: This study provides a unique molecular analysis of skin and throat isolates prospectively collected from persons with carriage and noninvasive infection in Africa. Despite high strain diversity, 4 clusters included two-thirds of the isolates, representing antigen priorities for broad vaccine coverage. In this rheumatic fever–endemic setting, pyoderma and skin carriage represent an important S. pyogenes reservoir and should be included in further surveillance studies and public health interventions. Clinical Trials Registration: NCT05117528.
Streptococcus pyogenes or Group A Streptococcus (GAS) remains a significant infectious problem around the world, particularly in low- and middle-income settings. Moreover, a recent invasive GAS infection (iGAS) upsurge has been observed in high-income settings. However, to date, no vaccine is available. Finding a good vaccine antigen and understanding the role of virulence factors in GAS infections have been hampered, in part, by technical difficulties to transform the many different strains and generate knockout mutants. Using colE1-type plasmid as a suicide vector, we have set up a method allowing the generation of non-polar mutants of GAS in 3 days. IMPORTANCE: Group A Streptococcus (GAS) is a major human pathogen, causing diseases ranging from mild and superficial infections of the skin and pharyngeal epithelium to severe systemic and invasive diseases. Since June 2022, several European countries, the US, and Australia are facing an upsurge of invasive life-threatening GAS infections. Finding a good vaccine antigen and understanding the role of virulence factors in GAS infections have been hampered, in part, by technical difficulties to transform the many different GAS strains and generate knockout mutants. Moreover, these tools must be adapted to a large range of different strains, since GAS are divided into more than 260 emm-types (M-type). We have set up a method allowing the generation of non-polar mutants of GAS in 3 days and in diverse backgrounds, which contrasts with previously published protocols.
Regarding the increased tendency to look at the M and M-like proteins as a functional trio, we set up a PCR-based typing of the enn and mrp genes in Group A Streptococcus (GAS). Based on a large mga regulon database, we have designed specific PCR primers for amplification and sequencing of enn and mrp genes. Primers were first validated in silico using a global database of 1,419 GAS genomes and then in vitro on 17 isolates covering all subclusters of Enn and Mrp proteins. Off-targets were also checked against other streptococci harboring M-like genes. We also described how to assign new Enn- and Mrp-types based on an up-to-date database available online. This new typing system will enhance the precision of strain characterization and help understand some differences between isolates sharing the same M-type. IMPORTANCE: Streptococcus pyogenes , also known as Group A Streptococcus , is a bacterium that causes a wide range of diseases, from mild sore throats to life-threatening infections and long-term complications like rheumatic heart disease. It is responsible for over 500,000 deaths a year. For decades, scientists have focused on the surface M protein which helps it survive in human tissues. The large diversity of its N-terminal region has led to the emm -typing system of S. pyogenes . However, the two M-like proteins, Enn and Mrp, produced by the same region of the genome, have been largely overlooked until recently. These proteins are found in many strains around the world, and recent findings suggest they also play an important role in S. pyogenes virulence. In our study, we developed a new typing system for Enn and Mrp proteins that aims to better understand their behavior and improve the monitoring of clinical strains.